Aeolus Pharmaceuticals Inc (AOLS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 09/30
| 03-2001 | 12-2000 | 09-2000 | 06-2000 | 03-2000 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -9,560 | -1,630 | -6,660 | -4,480 | -1,530 |
| Depreciation Amortization | 50 | 20 | 260 | 230 | 210 |
| Other Working Capital | -1,000 | 50 | -730 | -680 | -960 |
| Other Operating Activity | 5,100 | -730 | -1,800 | -1,950 | -2,690 |
| Operating Cash Flow | $-5,410 | $-2,290 | $-8,930 | $-6,880 | $-4,970 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -200 | -30 | -110 | -80 | -30 |
| Net Acquisitions | 0 | 0 | 0 | 11,000 | 11,000 |
| Other Investing Activity | 4,670 | 3,060 | 8,870 | 2,540 | 2,550 |
| Investing Cash Flow | $4,470 | $3,030 | $8,760 | $13,460 | $13,520 |
| Cash Flows From Financing Activities | |||||
| Other Financing Activity | 4,010 | -30 | -350 | -340 | -420 |
| Financing Cash Flow | $4,010 | $-30 | $-350 | $-340 | $-420 |
| Beginning Cash Position | 1,870 | 1,870 | 2,400 | 2,400 | 2,400 |
| End Cash Position | 4,950 | 2,580 | 1,870 | 8,640 | 10,520 |
| Net Cash Flow | $3,070 | $700 | $-530 | $6,230 | $8,110 |
| Free Cash Flow | |||||
| Operating Cash Flow | -5,410 | -2,290 | -8,930 | -6,880 | -4,970 |
| Free Cash Flow | -5,410 | -2,290 | -8,930 | -6,880 | -4,970 |